Rivaroxaban Evaluation in Real Life Settings

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

NCT02273700 ·Status: COMPLETED

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation

NCT02147444 ·Status: UNKNOWN

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

NCT03284762 ·Status: COMPLETED

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia

NCT01750788 ·Status: COMPLETED

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

NCT03772457 ·Status: UNKNOWN

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

NCT03684564 ·Status: COMPLETED ·Phase: PHASE2

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

NCT02387229 ·Status: TERMINATED ·Phase: PHASE3

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

NCT03749057 ·Status: COMPLETED ·Phase: PHASE4

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

NCT02784717 ·Status: COMPLETED

Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke

NCT07113184 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

NCT05262322 ·Status: COMPLETED

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

NCT02640222 ·Status: COMPLETED

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

NCT03746301 ·Status: COMPLETED

Repinotan in Patients With Acute Ischemic Stroke

NCT00044915 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well

NCT05764122 ·Status: WITHDRAWN ·Phase: PHASE2

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF

NCT06057467 ·Status: RECRUITING ·Phase: NA

RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke

NCT02129920 ·Status: UNKNOWN

Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema

NCT05399550 ·Status: WITHDRAWN ·Phase: PHASE2

TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

NCT02961348 ·Status: COMPLETED ·Phase: NA

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

NCT04218266 ·Status: COMPLETED ·Phase: PHASE2

Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial

NCT02818868 ·Status: COMPLETED

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

NCT07139314 ·Status: RECRUITING ·Phase: NA

Revive AIS Patients ImmeDiately

NCT03007082 ·Status: UNKNOWN

Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke

NCT06559436 ·Status: RECRUITING ·Phase: NA

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

NCT05691244 ·Status: RECRUITING ·Phase: PHASE3